Engineered bacteria as living cancer drugs
Bacteria that seek out the low-oxygen core of tumours, then manufacture a drug on the spot.
Attenuated Salmonella and other anaerobes colonise hypoxic tumour cores that drugs reach poorly, and can be engineered to secrete cytokines or enzymes. Live programmes on ClinicalTrials.gov in September 2026 include SGN1, an engineered Salmonella expressing methioninase (NCT05038150 and NCT05103345, phase 1/2, recruiting), and Saltikva, a Salmonella carrying IL-2, in phase 2 in metastatic pancreatic cancer (NCT04589234). The field has a long history of tolerable but ineffective results, beginning with VNP20009 in the 2000s.
How it works
Attenuated bacteria given intravenously or intratumourally replicate selectively in hypoxic, necrotic tumour regions and express a therapeutic payload locally.
- Reaches hypoxic cores that chemotherapy and radiation miss
- Payload made in situ, so systemic exposure is low
- Strongly immunogenic, which can convert cold tumours
- Historical trials showed colonisation without responses
- Sepsis and endotoxin risk forces heavy attenuation, which cuts potency
- Regulatory and biosafety burden of a replicating organism
Latest papers
topQuery for this technology: (TITLE:"Engineered bacteria as living cancer drugs" OR ABSTRACT:"Engineered bacteria as living cancer drugs") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Engineered bacteria as living cancer drugs, not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologyBacteriophage-based tumour delivery
Shares Oncolytic viruses, Radical oncology: what could change the war by 2035 and the tags frontier, radical.
- TechnologyTargeting the tumour's own microbes
Shares Radical oncology: what could change the war by 2035, Pancreatic ductal adenocarcinoma and the tags frontier, radical.
- TechnologyCAR-T against stroma: fibroblasts and myeloid cells
Shares Radical oncology: what could change the war by 2035, Pancreatic ductal adenocarcinoma and the tags frontier, radical.
- TechnologyDNA origami nanorobots
Shares Radical oncology: what could change the war by 2035 and the tags frontier, radical.
- TechnologyEpigenetic editing (durable gene silencing)
Shares Radical oncology: what could change the war by 2035 and the tags frontier, radical.
- TechnologyVery-high-energy electron therapy
Shares Radical oncology: what could change the war by 2035 and the tags frontier, radical.
- TechnologySenolytics and senescence-directed therapy
Shares Radical oncology: what could change the war by 2035 and the tags frontier, radical.
- TechnologyAntibody-oligonucleotide conjugates
Shares Radical oncology: what could change the war by 2035 and the tags frontier, radical.